Angioedema during therapy with recombinant tissue plasminogen activator

Br J Haematol. 1991 Apr;77(4):562-3.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angioedema / chemically induced*
  • Angioedema / immunology
  • Complement Activation / physiology
  • Female
  • Humans
  • Middle Aged
  • Recombinant Proteins / adverse effects
  • Tissue Plasminogen Activator / adverse effects*

Substances

  • Recombinant Proteins
  • Tissue Plasminogen Activator